SE-ATLAS

Mapping of Health Care Providers
for People with Rare Diseases

Akute myeloische Leukämie und myelodysplastische Syndrome durch Topoisomerase Typ II-Inhibitor

Further information on this disease (ORPHANET)

Care facilities 5